87 related articles for article (PubMed ID: 12152666)
21. [Changes in fast antiplasmin (alpha-2-antiplasmin) activity of the plasma of thoracotomized patients].
Fridrich L; Tuchmann A; Endler T; Meryn S; Moritz E
Prax Klin Pneumol; 1983 Oct; 37 Suppl 1():742-4. PubMed ID: 6647325
[No Abstract] [Full Text] [Related]
22. On the reaction of plasmin or plasmin-streptokinase complex with aprotinin or alpha 2-antiplasmin.
Wiman B
Thromb Res; 1980 Jan 1-15; 17(1-2):143-52. PubMed ID: 6154981
[No Abstract] [Full Text] [Related]
23. Enhancement of fibrinolysis in poorly controlled, hospitalized type 2 diabetic patients by short-term metabolic control: association with a decrease in plasminogen activator inhibitor 1.
Aso Y; Okumura KI; Yoshida N; Tayama K; Takemura Y; Inukai T
Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):175-80. PubMed ID: 15127320
[TBL] [Abstract][Full Text] [Related]
24. Antiplasmin activity of a peptide that binds to the receptor-binding site of angiogenin.
Gho YS; Yoon WH; Chae CB
J Biol Chem; 2002 Mar; 277(12):9690-4. PubMed ID: 11782452
[TBL] [Abstract][Full Text] [Related]
25. Laboratory evidence of hyperfibrinolysis in association with low plasminogen activator inhibitor type 1 activity.
Agren A; Wiman B; Schulman S
Blood Coagul Fibrinolysis; 2007 Oct; 18(7):657-60. PubMed ID: 17890953
[TBL] [Abstract][Full Text] [Related]
26. The predictive role of plasma TGF-beta1 during radiation therapy for radiation-induced lung toxicity deserves further study in patients with non-small cell lung cancer.
Zhao L; Sheldon K; Chen M; Yin MS; Hayman JA; Kalemkerian GP; Arenberg D; Lyons SE; Curtis JL; Davis M; Cease KB; Brenner D; Anscher MS; Lawrence TS; Kong FM
Lung Cancer; 2008 Feb; 59(2):232-9. PubMed ID: 17905467
[TBL] [Abstract][Full Text] [Related]
27. [The effect of plasmin and its complexes with alpha 2-macroglobulin and alpha 2-antiplasmin on the proliferative activity of human lymphocytes].
Musatov MI; Zhabin SG; Konenkov VI; Zorin NA
Biull Eksp Biol Med; 1994 Sep; 118(9):304-5. PubMed ID: 7529597
[No Abstract] [Full Text] [Related]
28. Oxidative stress effects fibrinolytic system in dialysis uraemic patients.
Pawlak K; Pawlak D; Mysliwiec M
Thromb Res; 2006; 117(5):517-22. PubMed ID: 15964061
[TBL] [Abstract][Full Text] [Related]
29. Plasma tissue factor antigen in localized prostate cancer: distribution, clinical significance and correlation with haemostatic activation markers.
Langer F; Chun FK; Amirkhosravi A; Friedrich M; Leuenroth S; Eifrig B; Bokemeyer C; Francis JL
Thromb Haemost; 2007 Mar; 97(3):464-70. PubMed ID: 17334515
[TBL] [Abstract][Full Text] [Related]
30. Thrombin activatable fibrinolysis inhibitor (TAFI) in stable angina pectoris patients undergoing coronary artery bypass grafting (CABG).
Lisowski P; Małyszko J; Hirnle T; Lisowska A; Jackowski R; Małyszko JS; Buzun L; Myśliwiec M
Rocz Akad Med Bialymst; 2005; 50():166-72. PubMed ID: 16358959
[TBL] [Abstract][Full Text] [Related]
31. Elevated urinary plasmin activity resistant to alpha2-antiplasmin in acute poststreptococcal glomerulonephritis.
Oda T; Tamura K; Yoshizawa N; Sugisaki T; Matsumoto K; Hattori M; Sawai T; Namikoshi T; Yamada M; Kikuchi Y; Suzuki S; Miura S
Nephrol Dial Transplant; 2008 Jul; 23(7):2254-9. PubMed ID: 18223261
[TBL] [Abstract][Full Text] [Related]
32. Alpha 2-antiplasmin's carboxy-terminal lysine residue is a major site of interaction with plasmin.
Hortin GL; Gibson BL; Fok KF
Biochem Biophys Res Commun; 1988 Sep; 155(2):591-6. PubMed ID: 2458720
[TBL] [Abstract][Full Text] [Related]
33. Plasmin system regulation in an ovalbumin-induced rat model of asthma.
Kucharewicz I; Mogielnicki A; Kasacka I; Buczko W; Bodzenta-Łukaszyk A
Int Arch Allergy Immunol; 2008; 147(3):190-6. PubMed ID: 18594148
[TBL] [Abstract][Full Text] [Related]
34. Circulating platelet-derived microparticles in systemic lupus erythematosus. Association with increased thrombin generation and procoagulant state.
Pereira J; Alfaro G; Goycoolea M; Quiroga T; Ocqueteau M; Massardo L; Pérez C; Sáez C; Panes O; Matus V; Mezzano D
Thromb Haemost; 2006 Jan; 95(1):94-9. PubMed ID: 16543967
[TBL] [Abstract][Full Text] [Related]
35. Haemostatic factors and the risk of cardiovascular death in patients with coronary artery disease: the AtheroGene study.
Morange PE; Bickel C; Nicaud V; Schnabel R; Rupprecht HJ; Peetz D; Lackner KJ; Cambien F; Blankenberg S; Tiret L;
Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2793-9. PubMed ID: 17023678
[TBL] [Abstract][Full Text] [Related]
36. Thrombin-antithrombin complex and alpha-plasmin inhibitor-plasmin complex levels in singleton and twin pregnancies.
Hayashi M; Fukasawa I; Inaba N
Int J Clin Pract; 2006 Oct; 60(10):1244-9. PubMed ID: 16669831
[TBL] [Abstract][Full Text] [Related]
37. Blood inhibitory capacity toward exogenous plasmin.
Banbula A; Zimmerman TP; Novokhatny VV
Blood Coagul Fibrinolysis; 2007 Apr; 18(3):241-6. PubMed ID: 17413760
[TBL] [Abstract][Full Text] [Related]
38. Effects of rhubarb extract on radiation induced lung toxicity via decreasing transforming growth factor-beta-1 and interleukin-6 in lung cancer patients treated with radiotherapy.
Yu HM; Liu YF; Cheng YF; Hu LK; Hou M
Lung Cancer; 2008 Feb; 59(2):219-26. PubMed ID: 17870203
[TBL] [Abstract][Full Text] [Related]
39. [Activation of fibrynolysis in children with chronic B or C hepatitis].
Michalska K; Szaflarska-Popławska A; Dymek G; Kotschy M
Pol Merkur Lekarski; 2004 Oct; 17(100):316-20. PubMed ID: 15690691
[TBL] [Abstract][Full Text] [Related]
40. The kinetics of plasmin inhibition by aprotinin in vivo.
Kang HM; Kalnoski MH; Frederick M; Chandler WL
Thromb Res; 2005; 115(4):327-40. PubMed ID: 15668193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
